Comprehensive Survey of AACR GENIE Database of Tumor Mutation Burden (TMB) among All Three Classes (I, II, III) of BRAF Mutated (BRAF+) NSCLC
Lung Cancer (Auckland, NZ)（2025）
Key words
target therapy,immunocheck point inhibitor (ici),braf mutation,tumor mutation burden (tmb),class i,ii,iii mutations
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined